| Literature DB >> 30072624 |
Yin-Ping Song1,2, Feng-Ping Miao3, Sheng-Tao Fang4, Xiu-Li Yin5, Nai-Yun Ji6.
Abstract
One new bisabolane sesquiterpene, bisabolan-1,10,11-triol (1), one new norbisabolane sesquiterpene, 12-nor-11-acetoxybisabolen-3,6,7-triol (2), two new naturally occurring monoterpenes, (7S)- and (7R)-1-hydroxy-3-p-menthen-9-oic acids (3 and 4), one new naturally occurring trichodenone, dechlorotrichodenone C (5), one new chlorine-containing trichodenone, 3-hydroxytrichodenone C (6), one new diketopiperazine, methylcordysinin A (7), and one new naturally occurring oxazole derivative, 4-oxazolepropanoic acid (8), were isolated from the culture of a marine brown alga-endophytic strain (cf44-2) of Trichoderma asperellum. Their structures and relative configurations were determined by extensive 1D/2D NMR and mass spectrometric data, and the absolute configurations of 3⁻6 were assigned by analysis of the ECD spectra aided by quantum chemical computations. Compounds 1, 2, 5, and 6 showed growth inhibition of some marine phytoplankton species and pathogenic bacteria.Entities:
Keywords: Trichoderma; diketopiperazine; oxazole; terpene; trichodenone
Mesh:
Substances:
Year: 2018 PMID: 30072624 PMCID: PMC6117674 DOI: 10.3390/md16080266
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–8.
1H and 13C NMR data for 1 and 2 (δ in ppm, J in Hz).
| Pos. | 1 (in CDCl3) | 2 (in CD3OD) | ||
|---|---|---|---|---|
| 1a | 3.44, td (10.5, 4.3) | 71.5, CH | 1.97, td (13.4, 2.9) | 27.8, CH2 |
| 1b | 1.57, m | |||
| 2a | 1.97, dddd (12.1, 4.2, 3.6, 2.0) | 45.3, CH2 | 1.88, td (13.6, 3.0) | 34.3, CH2 |
| 2b | 0.97, ddd (12.1, 12.1, 10.7) | 1.68, m | ||
| 3 | 1.42, m | 31.8, CH | 67.3, C | |
| 4a | 1.66, dm (12.9) | 34.7, CH2 | 5.73, dd (10.2, 1.6) | 136.8, CH |
| 4b | 0.84, m | |||
| 5a | 1.59, dq (13.2, 3.3) | 23.5, CH2 | 5.90, dd (10.2, 1.6) | 131.3, CH |
| 5b | 1.02, qd (13.1, 3.5) | |||
| 6 | 1.20, m | 49.0, CH | 74.9, C | |
| 7 | 2.03, m | 30.8, CH | 77.1, C | |
| 8a | 1.53, m | 32.7, CH2 | 1.73, m | 36.3, CH2 |
| 8b | 1.31, m | 1.40, m | ||
| 9a | 1.46, m | 29.8, CH2 | 1.51, m | 20.5, CH2 |
| 9b | 1.36, m | 1.41, m | ||
| 10a | 3.36, dd (9.9, 2.0) | 78.9, CH | 1.60, m | 37.7, CH2 |
| 10b | 1.52, m | |||
| 11 | 73.3, C | 4.89, m | 72.6, CH | |
| 12 | 1.16, s | 23.3, CH3 | ||
| 13 | 1.21, s | 26.7, CH3 | 1.22, d (6.3) | 20.2, CH3 |
| 14 | 0.81, d (6.9) | 14.0, CH3 | 1.10, s | 21.2, CH3 |
| 15 | 0.91, d (6.6) | 22.3, CH3 | 1.27, s | 30.3, CH3 |
| 16 | 172.8, C | |||
| 17 | 2.01, s | 21.3, CH3 | ||
Figure 2Key HMBC (arrows) and COSY (bold lines) correlations of 1–8.
Figure 3Key NOE correlations (arrows) of 1, 2, and 7.
1H NMR data for 3–8 (δ in ppm, J in Hz).
| Pos. | 3 (in CDCl3) | 4 (in CDCl3) | 5 (in CDCl3) | 6 (in CD3OD) | 7 (in CD3OD) | 8 (in CD3OD) |
|---|---|---|---|---|---|---|
| 2a | 2.19, d (18.0) | 2.16, brs | 2.45, m | 2.88, ddd (18.6, 6.3, 0.9) | 8.11, s | |
| 2b | 2.12, d (17.6) | 2.30, dd (18.6, 1.7) | ||||
| 3 | 5.54, brs | 5.54, brs | 2.64, m | 5.14, dd (6.3, 1.5) | 5.24, d (5.0) | |
| 4a | 2.05, dt (13.2, 3.3) | |||||
| 4b | 1.91, m | |||||
| 5a | 2.28, m | 2.18, m | 6.13, q (1.7) | 2.15, m | 7.69, s | |
| 5b | 2.04, brd (17.4) | 2.12, m | 2.15, m | |||
| 6a | 1.72, dt (13.0, 5.0) | 1.73, dt (13.1, 5.2) | 4.66, q (6.7) | 4.97, q (6.9) | 4.26, t (8.8) | 2.83, t (7.4) |
| 6b | 1.60, ddd (12.9, 8.5, 6.4) | 1.60, dt (13.1, 6.7) | ||||
| 7 | 3.13, q (6.8) | 3.13, q (6.9) | 1.45, d (6.7) | 1.51, d (6.9) | 2.64, t (7.4) | |
| 8 | 1.29, d (7.1) | 1.29, d (7.1) | ||||
| 9 | 4.09, dd (8.1, 4.0) | |||||
| 10a | 1.26, s | 1.25, s | 1.93, m | |||
| 10b | 1.52, m | |||||
| 11 | 1.89, m | |||||
| 12 | 0.99, d (6.4) | |||||
| 13 | 0.97, d (6.3) | |||||
| 14 | 3.37, s |
13C NMR data for 3–8 (δ in ppm).
| Pos. | 3 (in CDCl3) | 4 (in CDCl3) | 5 (in CDCl3) | 6 (in CD3OD) | 7 (in CD3OD) | 8 (in CD3OD) |
|---|---|---|---|---|---|---|
| 1 | 68.6, C | 68.7, C | 209.7, C | 200.1, C | 171.1, C | |
| 2 | 39.8, CH2 | 39.8, CH2 | 35.4, CH2 | 44.0, CH2 | 153.4, CH | |
| 3 | 121.8, CH | 122.0, CH | 27.9, CH2 | 68.4, CH | 88.5, CH | |
| 4 | 135.6, C | 135.6, C | 184.4, C | 175.4, C | 31.8, CH2 | 140.1, C |
| 5 | 24.3, CH2 | 24.1, CH2 | 128.1, CH | 131.5, C | 25.3, CH2 | 136.5, CH |
| 6 | 35.4, CH2 | 35.4, CH2 | 68.0, CH | 66.3, CH | 60.5, CH | 22.4, CH2 |
| 7 | 46.3, CH | 46.3, CH | 22.2, CH3 | 21.8, CH3 | 173.6, C | 33.7, CH2 |
| 8 | 15.6, CH3 | 15.7, CH3 | 176.2, C | |||
| 9 | 179.5, C | 179.7, C | 55.0, CH | |||
| 10 | 28.6, CH3 | 28.4, CH3 | 38.8, CH2 | |||
| 11 | 25.9, CH | |||||
| 12 | 23.4, CH3 | |||||
| 13 | 22.0, CH3 | |||||
| 14 | 57.4, CH3 |
Figure 4Experimental and calculated ECD spectra of 3–6.
Antimicroalgal and antibacterial activities of 1, 2, 5, and 6.
| IC50 (μg/mL) | Inhibitory Zone Diameter (mm) at 20 μg/disk | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| – a | 30 | 27 | – b | 6.7 | 6.5 | 6.5 | 6.3 |
|
| 15 | 8.4 | 10 | 14 | 6.4 | 7.5 | 7.0 | 6.3 |
|
| 4.2 | 7.2 | 8.5 | 6.9 | 6.2 | 7.0 | 6.5 | 6.2 |
|
| 30 | 35 | 39 | 37 | 6.7 | 8.5 | 8.0 | 6.5 |
| K2Cr2O7 | 0.46 | 0.98 | 0.89 | 1.92 | ||||
| chloramphenicol | 20 | 18 | 18 | 19 | ||||
a Inhibition rate was 65% at 100 μg/mL. b Inhibition rate was 50% at 100 μg/mL.